ISSN: 1859 - 2872
Studying the clinical and brain magnetic resonance images characteristics in patients with brain metastases from non-small cell lung cancer
Main Article Content
Keywords
Non-small cell lung cancer, brain metastases
Abstract
Objective: To comment on the clinical, brain MRI characteristics in patients with brain metastases from non-small cell lung cancer. Subject and method: A prospective study in 104 patients with brain metastases from non-small cell lung cancer, from February 2017 to September 2018. Result and conclusion: The mean age was 59, mainly under 65 years old (75.3%), male was 89.4%, adenocarcinoma 93.3%. EGFR (+) 52.9%. Asymptomatic patients was 59.6%. Size of brain metastases ≤ 2cm (73.1%), 1 - 2 tumors was 55.8%. Brain tumor with ring enhancement was 73.1%, peritumoral edema was 60.6%.
Article Details
References
1. Lê Văn Nguyên, Nguyễn Đình Tiến, Lê Hùng Trường (2016) Nghiên cứu đặc điểm lâm sàng, cộng hưởng từ sọ não và kết quả điều trị di căn não do ung thư phổi không tế bào nhỏ bằng xạ phẫu CyberKnife. Tạp chí Y Dược Lâm sàng 108, tập 11, số 3, tr. 498-503.
2. Phạm Văn Thái, Mai Trọng Khoa, Phạm Duy Hiển và CS (2013) Đánh giá hiệu quả điều trị khối u di căn não từ ung thư phổi không tế bào nhỏ bằng xạ phẫu dao gamma quay. Tạp chí Ung thư học Việt Nam, số 1, tr. 209-215.
3. Ayabe E, Kaira K, Harada H et al (2015) Prognosis of patients with brain metastasis from non-small cell lung cancer according to gefitinib administration. Announcement 1(5).
4. Edge SB, Byrd DR, Compton CC et al (2010) AJCC Cancer Staging Manual 7th ed. New Yoek: Spinger.
5. Kelly WJ, Shah NJ, Subramaniam DS (2018) Management of brain metastases in epidermal growth factor receptor mutant non-small cell lung cancer. Front Oncol 8: 208.
6. Kondriolka D, Niranijan A (2007) Radiology of radiosurgery. Prog Neurol Surg. Bassel Karger 20: 16-27.
7. Nakahama K, Tamiya A, Taniguchi Y et al (2017) Comparing gefitinib and erlotinib with regard to brain metastases recurrence in EGFR mutant non-small cell lung cancer patients. Clin Exp Oncol 6(4).
8. NCCN Clinical Practice Guidelines in Oncology (2018) Non-small cell lung cancer.
2. Phạm Văn Thái, Mai Trọng Khoa, Phạm Duy Hiển và CS (2013) Đánh giá hiệu quả điều trị khối u di căn não từ ung thư phổi không tế bào nhỏ bằng xạ phẫu dao gamma quay. Tạp chí Ung thư học Việt Nam, số 1, tr. 209-215.
3. Ayabe E, Kaira K, Harada H et al (2015) Prognosis of patients with brain metastasis from non-small cell lung cancer according to gefitinib administration. Announcement 1(5).
4. Edge SB, Byrd DR, Compton CC et al (2010) AJCC Cancer Staging Manual 7th ed. New Yoek: Spinger.
5. Kelly WJ, Shah NJ, Subramaniam DS (2018) Management of brain metastases in epidermal growth factor receptor mutant non-small cell lung cancer. Front Oncol 8: 208.
6. Kondriolka D, Niranijan A (2007) Radiology of radiosurgery. Prog Neurol Surg. Bassel Karger 20: 16-27.
7. Nakahama K, Tamiya A, Taniguchi Y et al (2017) Comparing gefitinib and erlotinib with regard to brain metastases recurrence in EGFR mutant non-small cell lung cancer patients. Clin Exp Oncol 6(4).
8. NCCN Clinical Practice Guidelines in Oncology (2018) Non-small cell lung cancer.
Article Sidebar
How to Cite
Nguyen MinhH. (2018). Studying the clinical and brain magnetic resonance images characteristics in patients with brain metastases from non-small cell lung cancer. Tạp Chí Y Dược lâm sàng 108, 13(8), 19-24. Retrieved from https://tcydls108.benhvien108.vn/index.php/YDLS/article/view/577